Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Make a choice that matters
The best care starts with the best information
Read the RheumWATCH archives on topics such as rheumatology advocacy, policy updates, insurance advocacy, and practice management.
Calling all advocates! On September 12-13, ACR and ARHP physicians, health professionals, and patients will converge on our nation’s capital to make our voices heard for rheumatology. The Advocates for Arthritis fly-in includes advocacy training, prominent guest speakers, and visits with your senators and representatives in Congress.
Please visit the Advocates for Arthritis page to learn more about the program and fill out the survey application by July 1.
Each year, the ACR also welcomes patients to participate in Advocates for Arthritis. If you know of a patient who has a compelling story, or would be a strong advocate to communicate the importance of access to treatments, access to rheumatology, and access to care, please encourage them to apply!
The ACR covers travel and costs for participants in this important experience to affect health policy and the future of our subspecialty.
The ACR recommends that all members subject to the Meaningful Use program apply for the hardship exemption by July 1, even if you submitted Meaningful Use and expect not to receive a penalty. CMS has clarified that submission of a hardship exception application does not prevent a provider from attesting and receiving an incentive payment if Meaningful Use requirements are met. If you or your practice did not successfully meet Meaningful Use for an EHR reporting period in 2015, the deadline to apply for an exemption is July 1, 2016.
Earlier this year as part of efforts to allow physicians to avoid a potential three percent penalty in 2017, the ACR, AMA, and other groups worked for the successful passage of a law allowing CMS to provide blanket hardship exemptions from 2015 Meaningful Use penalties to providers who apply. The exemption would prevent financial penalties scheduled for 2017.
The application and instructions are available on the CMS EHR Incentive Programs website. Both individual and group application processes are now available, the latter of which allows more than one physician to apply at once. You can also access a checklist created by CMS for more information.
Last month, CMS released its final Quality Measure Development Plan. This will serve as the agency’s framework for clinician quality measure development in support of the Merit-Based Incentive Payment System (MIPS) and alternative payment models (APMs) components of MACRA. The agency had posted its draft plan in late 2015 with a request for feedback. Read the ACR comments >
Under the Medicare Access and CHIP Reauthorization Act (MACRA), the Quality Measure Development Plan will be an integral framework supporting payment programs. Noting that success of quality payment programs under MACRA will require collaboration with many stakeholders, including physician specialty organizations, CMS thanked those who commented on the plan.
The finalized Quality Measure Development Plan will include:
Get ready for success under MACRA by catching up on all the latest MACRA news and resources for you and your practice.
When I began my tenure as ACR president this past November, I posited that it “takes a village” to grow and succeed in rheumatology’s rapidly changing environment. The ACR village includes volunteers who represent a diverse leadership pipeline reflecting the demographics of our younger members. It also includes the international rheumatology community that accounts for over 50% of the attendance at our Annual Meeting. The ACR’s Lupus Initiative serves as a vivid example of how we have expanded our village.
The Lupus Initiative (TLI) began in 2009 when the ACR was awarded a one-year cooperative agreement with the U.S. Department of Health and Human Services, Office of Minority Health to develop provider-focused education resources aimed at reducing health disparities in lupus. Almost seven years later it has evolved into a multi-faceted lupus program that receives funding from multiple sources and includes development and dissemination of education resources for providers, students and patients, and the pilot testing of education programs to increase frontline provider knowledge about lupus. In October 2015, TLI was propelled into the national spotlight after the ACR received a grant from the Centers for Disease Control and Prevention (CDC) to create and implement a national lupus public awareness and education campaign to build sustainable lupus awareness, knowledge, skills and partnerships. The ACR’s CDC project has three components: (1) dissemination of immediately available lupus education resources, (2) development of a national lupus awareness media campaign and (3) grassroots, community-tailored, local-level activities.
To support the CDC project, the ACR is utilizing its existing village of local rheumatology societies. Just months into the project, the ACR has already exceeded its 2016 dissemination goals. Twenty-five state rheumatology societies have committed to help the ACR disseminate lupus information to providers and patients. Eight societies have already distributed lupus education resources to its constituents. Additional partnerships include:
Other ACR members who have been integral to efforts to promote lupus awareness include: Stacy Ardoin, MD, Childhood Arthritis and Rheumatology Research Alliance, Maria Dall’Era, MD, University of California San Francisco, Elizabeth Ferucci, MD, Alaska Native Tribal Health Consortium, Peter Izmirly, MD, New York University, Emily Somers, MD, ScM, University of Michigan, and Jinoos Yazdany, MD, MPH, University of California San Francisco.
The Lupus Initiative has been so successful that the ACR has established a Collaborative Initiatives department. As the name suggests, the department’s target stakeholders include a broad circle of collaborators and partners, including ACR and ARHP members in private practice and academia, as well as private, public and not for profit entities. The department uses lupus and other rheumatic diseases as case studies to advance health equity, eliminate health disparities and improve the quality of patient lives.
Recently, ACR leadership established a working group of ACR and ARHP members to guide the strategic direction of the Collaborative Initiatives department. The inaugural volunteer members are Greg Dennis, MD, Candace Feldman, MD, MPH, David Karp, MD, PhD (ACR Board liaison), Bernardo A. Pons-Estel, MD (international member), Jillian A. Rose, LMSW (ARHP member), and S. Sam Lim, MD, MPH (chair). Over the next several months, the working group will identify relevant funding and commercialization opportunities, provide guidance on expanding the reach of the current projects, and ensure alignment of activities with the ACR mission, vision and core values, as well as ensuring the continued vitality of The Lupus Initiative.
I welcome your feedback and suggestions to continue to expand the ACR village, raise awareness about lupus, and decrease health disparities for our patients with rheumatic diseases.
Provider, patient, educator and student resources are available at thelupusinitiative.org.
Joan M. Von Feldt, MD, MSEd